Professor Peter MacCallumProfessor in HaematologyEmail: p.k.maccallum@qmul.ac.uk Telephone: +44 (0) 20 7882 6203ProfileResearchPublicationsSupervisionProfileI am a clinical academic at the Wolfson Institute of Population Health, Queen Mary University of London, and an honorary consultant haematologist at Barts Health NHS Trust where I lead the clinical and laboratory thrombosis service at St Bartholomew’s and the Royal London Hospitals. My research interests cover the field of venous thromboembolism (VTE) and mirror my clinical practice. Much clinical and research time since March 2020 has been taken up with firstly the thrombotic complications of COVID-19 and subsequently the diagnosis and management of vaccine-induced thrombosis with thrombocytopenia. Over the past 5 years I have been Chief Investigator of the ORANGE study, a prospective UK-based registry of outcomes of major bleeding on oral anticoagulants and the largest such study globally, and National Co-ordinating Investigator for GARFIELD-VTE, a prospective global registry that studied the management and outcomes of >10,000 patients with a new episode of VTE from >30 countries and to which the UK was the largest contributor (>900 patients). Future plans include a collaboration to better understand the pathways of coagulation activation in patients with cancer, who contribute 10-20% of the population burden of VTE and for whom thrombosis is a leading cause of death. I have additionally authored chapters on thrombosis in major UK textbooks including the Oxford Textbook of Medicine, Kumar and Clark’s Clinical Medicine, and Postgraduate Haematology. I regularly teach medical students in PBLs and tutorials and some of my students have gone on to present findings from their specialist study modules at national and international conferences. I also act as student mentor. Despite the problems resulting from the COVID-19 pandemic my current MD(Res) student passed her viva within 4 years.ResearchResearch Interests:Thrombosis – epidemiology; pathogenesis of cancer-associated thrombosis; diagnosis, prevention and management of venous thromboembolism; personalised medicine approach to VTE management PublicationsGreen L, Tan J, Morris JK, Alikhan R, Curry N, Everington T, Maclean R, Saja K, Stanworth S, Tait C, MacCallum P. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). Haematologica 2018;103:738-45. doi: 10.3324/haematol.2017.182220. Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs R, Petrou S, Dale J, Poole CJ, Levine M. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol 2018;36:2017-23. doi: 10.1200/JCO.2018.78.8034. Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. New Engl J Med 2020;383:288-90. DOI: 10.1056/NEJMc2013656 Prandoni P, Haas S, Fluharty M et al. (2024). Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry. nameOfConference DOI: 10.1016/j.thromres.2024.01.023 QMRO: qmroHref Barco S, Virdone S, Götschi A et al. (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. nameOfConference DOI: 10.1016/j.thromres.2023.08.009 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90362 Kohli R, Platton S, Forbes S et al. (2023). Renal transplant and hemostasis: early postoperative changes in recipients and donors. nameOfConference DOI: 10.1016/j.rpth.2023.100168 QMRO: qmroHref Platton S, Hill C, Lester W et al. (2023). Effect of argatroban on laboratory measurement of fibrinogen activity in ex vivo samples – Potential for errors in clinical decision‐making. nameOfConference DOI: 10.1111/ijlh.14061 QMRO: qmroHref Turpie AGG, Farjat AE, Haas S et al. (2023). 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. nameOfConference DOI: 10.1016/j.thromres.2022.11.016 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91622 Haas S, Farjat AE, Pieper K et al. (2022). On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. nameOfConference DOI: 10.1055/s-0042-1757744 QMRO: qmroHref Kohli R, Allen E, Platton S et al. (2022). Effect on haemostasis of different replacement fluids during therapeutic plasma exchange—A comparative multicentre observational study. nameOfConference DOI: 10.1002/jca.22008 QMRO: qmroHref Cools F, Virdone S, Sawhney J et al. (2022). Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. nameOfConference DOI: 10.1016/s2352-3026(22)00173-9 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80643 Kohli R, Geneen LJ, Brunskill SJ et al. (2022). Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used. nameOfConference DOI: 10.1002/jca.21996 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79427 Arachchillage DJ, Mackillop L, Chandratheva A et al. (2022). Thrombophilia testing: A British Society for Haematology guideline. nameOfConference DOI: 10.1111/bjh.18239 QMRO: qmroHref Gardiner C, Mackie IJ, MacCallum P et al. (2022). Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients. nameOfConference DOI: 10.1111/ijlh.13855 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78606 Higgins H, Andrews N, Stowe J et al. (2022). Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England. nameOfConference DOI: 10.1002/rth2.12698 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78679 Cohen AT, Lewis M, Connor A et al. (2022). Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding. nameOfConference DOI: 10.1002/emp2.12655 QMRO: qmroHref Entwistle NMA, Ricketts W, Thedoulou A et al. (2022). Postdischarge complications and mortality of hospitalised patients with COVID-19 in East London Hospitals. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78871 Platton S, Schönborn L, Charrot S et al. (2022). Vaccine‐induced immune thrombocytopenia and thrombosis: The decline in anti‐platelet factor 4 antibodies is assay‐dependent. nameOfConference DOI: 10.1111/bjh.18022 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78870 Cohen O, Ageno W, Farjat AE et al. (2022). Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE. nameOfConference DOI: 10.1111/jth.15574 QMRO: qmroHref Weitz JI, Farjat AE, Ageno W et al. (2021). Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE. nameOfConference DOI: 10.1111/jth.15520 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74149 Platton S, Bartlett A, MacCallum P et al. (2021). Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination. nameOfConference DOI: 10.1111/jth.15362 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74145 Goto S, Turpie AGG, Farjat AE et al. (2021). The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. nameOfConference DOI: 10.1016/j.thromres.2021.05.007 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78607 Jerjes-Sánchez C, Rodriguez D, Farjat AE et al. (2021). Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. nameOfConference DOI: 10.1055/s-0040-1722611 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74144 Makariou N, Mills S, Bariana T et al. (2021). Virtual clinics - the future of thrombosis and anticoagulant consultations? A patient preference survey.. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78502 Tan J, Maccallum P, Curry N et al. (publicationYear). Correction of International Normalised Ratio in major bleeding related to vitamin K antagonists is associated with better survival: a UK study. nameOfConference DOI: 10.1016/j.thromres.2020.11.011 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68383 Bowles L, Platton S, Yartey N et al. (2020). Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.. nameOfConference DOI: 10.1056/NEJMc2013656 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64038 Weitz JI, Haas S, Ageno W et al. (2020). Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. nameOfConference DOI: 10.1007/s11239-020-02180-x QMRO: qmroHref Kohli R, Estcourt L, Zaidi A et al. (2020). Efficacy and safety of chemical thromboprophylaxis in renal transplantation – A systematic review. nameOfConference DOI: 10.1016/j.thromres.2020.05.013 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64347 Cohen AT, Lewis M, Connor A et al. (2020). 30 DAY MORTALITY FOLLOWING ANDEXANET ALFA IN ANNEXA-4 COMPARED WITH PROTHROMBIN COMPLEX CONCENTRATE (PCC) THERAPY IN THE ORANGE STUDY FOR LIFE THREATENING NON-VITAMIN K ORAL ANTICOAGULANT (NOAC) RELATED BLEEDING. nameOfConference DOI: 10.1016/s0735-1097(20)32869-2 QMRO: qmroHref Kohli R, Estcourt L, Zaidi A et al. (2020). A systematic review of efficacy and safety of chemical thromboprophylaxis in renal transplantation. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64763 Mehta D, Jones DM, Guha A et al. (2020). DOACs for stroke prevention in patients with AF and cancer.. nameOfConference DOI: 10.5837/bjc.2020.036 QMRO: qmroHref Haywood M, Bowles L, Platton S et al. (2020). Heparin-induced thrombocytopaenia (HIT): an audit of the diagnostic pathway at Barts Health NHS Trust. nameOfConference DOI: doi QMRO: qmroHref Poynton M, Hibbs S, MacCallum P et al. (2020). Incidence and management of PEGylated-asparaginase related thrombosis in adults with ALL. nameOfConference DOI: doi QMRO: qmroHref Todd S, Sivapathasuntharam D, Bowles L et al. (2020). Management of traumatic intracranial haemorrhage in elderly patients on anticoagulation: a trauma centre experience. nameOfConference DOI: doi QMRO: qmroHref MacCallum PK, Bowles L (2020). Thrombosis in pregnancy. nameOfConference DOI: 10.1093/med/9780198746690.003.0269 QMRO: qmroHref Chahal JK, Antoniou S, Earley M et al. (2019). Preventing strokes in people with atrial fibrillation by improving ABC.. nameOfConference DOI: 10.1136/bmjoq-2019-000783 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62358 Green L, Tan J, Antoniou S et al. (2019). Haematological management of major bleeding associated with direct oral anticoagulants – UK experience. nameOfConference DOI: 10.1111/bjh.15808 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/61106 Kohli R, Forbes S, Thuraisingham R et al. (2019). Survey of thromboprophylaxis strategies in renal transplant recipients at a single transplant unit. nameOfConference DOI: doi QMRO: qmroHref Carroll R, Mansell J, Platton S et al. (2018). The Future of Activated Clotting Time?. nameOfConference DOI: 10.1213/ANE.0000000000003443 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/41965 MacCallum PK, Thomson JM, Poller L (1990). Effects of Fixed Minidose Warfarin on Coagulation and Fibrinolysis Following Major Gynaecological Surgery. nameOfConference DOI: 10.1055/s-0038-1647349 QMRO: qmroHref Young AM, Marshall A, Thirlwall J et al. (2018). Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).. nameOfConference DOI: 10.1200/JCO.2018.78.8034 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/41063 Green L, Tan J, Morris JK et al. (2018). A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). nameOfConference DOI: 10.3324/haematol.2017.182220 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/32046 Wedzicha JA, Seemungal TA, MacCallum PK et al. (2000). Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels. nameOfConference DOI: 10.1055/s-0037-1613998 QMRO: qmroHref MacCallum PK, Cooper JA, Martin J et al. (2000). Haemostatic and Lipid Determinants of Prothrombin Fragment F1.2 and D-dimer in Plasma. nameOfConference DOI: 10.1055/s-0037-1613831 QMRO: qmroHref MacCallum PK, Cooper JA, Howarth DJ et al. (1998). Sex Differences in the Determinants of Fibrinolytic Activity. nameOfConference DOI: 10.1055/s-0037-1614950 QMRO: qmroHref Green L, Tan J, Grist C et al. (2017). Aetiology and outcome of massive transfusion in two large London teaching hospitals over a 3-year period (2012–2014). nameOfConference DOI: 10.1111/tme.12434 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/61101 Collins J, Bowles L, MacCallum PK (2016). Prevention and management of venous thromboembolism in pregnancy. nameOfConference DOI: 10.12968/hmed.2016.77.12.c194 QMRO: qmroHref MacCallum P (2001). Book Review. nameOfConference DOI: 10.1080/10245332.2001.11746591 QMRO: qmroHref Platton S, Bowles L, MacCallum P (2017). Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents. nameOfConference DOI: 10.1111/bjh.14230 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/16008 Poller L, Thomson JM, MacCallum PK et al. (1995). Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity. nameOfConference DOI: 10.1177/107602969500100404 QMRO: qmroHref Benbow EW, Love EM, Love HG et al. (1987). Massive Right Atrial Thrombus Associated with a Chiari Network and a Hickman Catheter. nameOfConference DOI: 10.1093/ajcp/88.2.243 QMRO: qmroHref (2016). Antiphospholipid syndrome: pathophysiology, diagnosis and treatment. nameOfConference DOI: 10.1211/cp.2016.20201318 QMRO: qmroHref Collins J, Greinacher A, MacCallum P (2016). Autoimmune heparin-induced thrombocytopenia: A case report. nameOfConference DOI: doi QMRO: qmroHref Platton SJM, Bowles L, MacCallum PK (2016). Dilute Russell's viper venom time - potential use for the detection of apixaban and rivaroxaban predicted from interference in lupus anticoagulant testing. nameOfConference DOI: doi QMRO: qmroHref Platton SJM, Bowles L, MacCallum PK (2016). Effects of rivaroxaban and apixaban on routine coagulation screening tests. nameOfConference DOI: doi QMRO: qmroHref Tait CR, Morris JK, Tan J et al. (2016). Trends in oral anticoagulant prescriptions and major bleeding complications: A comparison of NHS CCG prescription data with cases from a prospective study (ORANGE) between October 2013 and June 2015. nameOfConference DOI: doi QMRO: qmroHref Renukanthan A, Quinton R, Turner B et al. (2015). Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia. nameOfConference DOI: 10.1007/s12020-015-0562-5 QMRO: qmroHref Kalkur P, Kreze O, Chauhan N et al. (2015). Direct oral anti-coagulants for prevention of stroke and systemic embolism in non-valvular atrial fibrillation - Barts Health experience across two sites. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/7629 Green L, Morris J, Alikhan R et al. (2015). Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study. nameOfConference DOI: doi QMRO: qmroHref Frise CJ, MacCallum PK, Mackillop LH et al. (2015). Systemic Thromboembolism in Pregnancy: Thromboprophylaxis. nameOfConference DOI: 10.1007/978-3-319-15120-5_4 QMRO: qmroHref Badle S, Coppack S, MacCallum P (2015). Thromboprophylaxis in a patient with morbid obesity. nameOfConference DOI: doi QMRO: qmroHref Green L, Alikhan R, Curry N et al. (2014). Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study.. nameOfConference DOI: 10.1111/bjh.12968 QMRO: qmroHref MacCallum P, Bowles L, Keeling D (2014). Diagnosis and management of heritable thrombophilias.. nameOfConference DOI: 10.1136/bmj.g4387 QMRO: qmroHref Dadgar M, Pickford G, MacCallum P et al. (2014). PWE-080 Beware The Interaction Between Thiopurines And Warfarin. nameOfConference DOI: 10.1136/gutjnl-2014-307263.340 QMRO: qmroHref Robson J, Dostal I, Mathur R et al. (2014). Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.. nameOfConference DOI: 10.3399/bjgp14X679705 QMRO: qmroHref Rahiminejad M, Rastogi A, Prabhudesai S et al. (2014). Evaluating the Use of a Negative D-Dimer and Modified Low Wells Score in Excluding above Knee Deep Venous Thrombosis in an Outpatient Population, Assessing Need for Diagnostic Ultrasound.. nameOfConference DOI: 10.1155/2014/519875 QMRO: qmroHref Sinha S, Hossain U, MacCallum P (2014). SCREENING FOR MALIGNANCY IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM. nameOfConference DOI: doi QMRO: qmroHref Maccallum PK, Mathur R, Hull SA et al. (2013). Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study.. nameOfConference DOI: 10.1136/bmjopen-2013-003343 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13142 MacCallum PK, Mathur R, Hull SA et al. (2013). Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation. nameOfConference DOI: 10.1136/bmjopen-2013-003343 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/6293 Van der Krogt L, Barber C, MacCallum P et al. (2013). Retrospective study of the Massive Haemorrhage Protocol adherence in the management of trauma-induced bleeding at the Royal London Hospital. nameOfConference DOI: doi QMRO: qmroHref MacCallum PK (2013). COPD and thrombosis. nameOfConference DOI: 10.1183/1025448x.10012512 QMRO: qmroHref Raza I, Davenport R, Rourke C et al. (2013). The incidence and magnitude of fibrinolytic activation in trauma patients.. nameOfConference DOI: 10.1111/jth.12078 QMRO: qmroHref Mpouzouki A, Bowles L, Beski S et al. (2013). A retrospective review of risk factors for thrombosis in women presenting with venous thromboembolism (VTE) during pregnancy and the puerperium. nameOfConference DOI: 10.1016/S0049-3848(13)70070-7 QMRO: qmroHref Platton SJ, Nahar B, Dale C et al. (2013). False-positive results for a lupus anticoagulants occur in patients on low molecular weight heparin but not fondaparinux, by dilute activated partial thromboplastin time. nameOfConference DOI: doi QMRO: qmroHref Frise CJ, MacCallum PK, Mackillop LH et al. (2012). Systemic Thromboembolism in Pregnancy: Thromboprophylaxis. nameOfConference DOI: 10.1007/978-1-4471-4411-3_3 QMRO: qmroHref Verghese L, Alam S, Beski S et al. (2012). Antenatal screening for pre-eclampsia: evaluation of the NICE and pre-eclampsia community guidelines.. nameOfConference DOI: 10.3109/01443615.2011.635224 QMRO: qmroHref Kint M, Platton S, Hart D et al. (2012). A retrospective study of thrombophilia testing requests in a large teaching hospital. nameOfConference DOI: 10.1016/j.thromres.2012.08.238 QMRO: qmroHref Pandya J, Islam A, MacCallum P et al. (2012). A single-centre retrospective study of prothrombin complex concentrate (octaplex) use. nameOfConference DOI: doi QMRO: qmroHref Provan D, Newland AC, MacCallum PK (2011). Acquired disorders affecting megakaryocytes and platelets. nameOfConference DOI: 10.1016/B978-0-7020-3147-2.00033-X QMRO: qmroHref MacCallum PK, Ashby D, Hennessy EM et al. (2011). Cumulative flying time and risk of venous thromboembolism.. nameOfConference DOI: 10.1111/j.1365-2141.2011.08899.x QMRO: qmroHref Davenport R, Manson J, De'Ath H et al. (2011). Functional definition and characterization of acute traumatic coagulopathy.. nameOfConference DOI: 10.1097/CCM.0b013e3182281af5 QMRO: qmroHref Agarwal N, Deinde O, Willmott F et al. (2011). A case series of interventional radiology in postpartum haemorrhage.. nameOfConference DOI: 10.3109/01443615.2011.566388 QMRO: qmroHref Provan D, Newland AC, MacCallum PK (2011). Acquired disorders affecting megakaryocytes and platelets. nameOfConference DOI: 10.1016/B978-0-7020-3147-2.00033-X QMRO: qmroHref Davenport R, Manson J, De'Ath H et al. (2011). Point of care diagnostics for the rapid identification of acute traumatic coagulopathy and prediction of massive trauma haemorrhage. nameOfConference DOI: doi QMRO: qmroHref Prabhudesai SG, Rastogi A, Platton S et al. (2011). Evaluating the use of negative D-Dimer and low wells score in excluding above knee deep venous thrombosis in an outpatient population at a major London teaching hospital. nameOfConference DOI: doi QMRO: qmroHref Varma G, Mills S, Gutteridge C et al. (2011). Implementation of a venous thromboembolism (VTE) risk assessment tool to improve inpatient thromboprophylaxis. nameOfConference DOI: doi QMRO: qmroHref Raza I, Davenport R, Rourke C et al. (2011). Occult activation of fibrinolysis in trauma. nameOfConference DOI: doi QMRO: qmroHref Uprichard J, Boomla K, Mills S et al. (2011). The incidence of venous thromboembolism (VTE) in East London. nameOfConference DOI: doi QMRO: qmroHref Uprichard J, Mills S, MacCallum PK et al. (2011). The use of an electronic patient record to improve patient safety for anticoagulation. nameOfConference DOI: doi QMRO: qmroHref Posner C, Owen M, Melhem N et al. (2010). An acutely swollen leg. nameOfConference DOI: 10.7861/clinmedicine.10-5-484 QMRO: qmroHref Rao AP, Bojahr H, Beski S et al. (2010). Role of interventional radiology in the management of morbidly adherent placenta. nameOfConference DOI: 10.3109/01443615.2010.509823 QMRO: qmroHref Rudnicka AR, MacCallum PK, Whitelocke R et al. (2010). Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.. nameOfConference DOI: 10.1038/eye.2010.8 QMRO: qmroHref Coleman R, MacCallum P (2010). Treatment and secondary prevention of venous thromboembolism in cancer. nameOfConference DOI: 10.1038/sj.bjc.6605601 QMRO: qmroHref Saha A, Nguyen T, Watson C et al. (2010). The implementation of a simple step-wise intervention which dramatically improved the thromboprophylaxis rate in medical cancer patients. nameOfConference DOI: 10.1016/s0049-3848(10)70112-2 QMRO: qmroHref Macey MG, Bevan S, Alam S et al. (2010). Platelet activation and endogenous thrombin potential in pre-eclampsia.. nameOfConference DOI: 10.1016/j.thromres.2009.09.013 QMRO: qmroHref Tillotson GS (2009). Introduction: Medical Education. nameOfConference DOI: 10.1378/chest.09-2269 QMRO: qmroHref Meade TW, MacCallum PK (2005). Coagulation, thrombosis, and coronary heart disease. nameOfConference DOI: 10.1093/acprof:oso/9780198525738.003.0029 QMRO: qmroHref Truss NJ, Beavis J, Maccallum PK et al. (2009). Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates. nameOfConference DOI: 10.1111/j.1538-7836.2009.03466.x QMRO: qmroHref Poller L, Keown M, Ibrahim S et al. (2009). A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. nameOfConference DOI: 10.1160/TH08-10-0664 QMRO: qmroHref MacCallum PK, Mt-Isa S, Whyte K et al. (2009). Air travel and risk of venous thromboembolism: a community-based study. nameOfConference DOI: doi QMRO: qmroHref Hogg M, MacCallum P, Beski S (2009). Angiomyolipoma with renal vein thrombosis in pregnancy: a case report and review of the literature. nameOfConference DOI: 10.1016/s0049-3848(09)70103-3 QMRO: qmroHref Rudnicka AR, MacCallum PK, Whitelocke R et al. (2009). Circulating markers of arterial thrombosis and age-related maculopathy: a case-control study. nameOfConference DOI: doi QMRO: qmroHref Hossain SR, Madhani M, Varma G et al. (2009). Measures to improve safety of warfarinized patients following hospital discharge. nameOfConference DOI: doi QMRO: qmroHref Greaves P, Madhani M, Hallam S et al. (2009). Off-license use of recombinant factor VIIa: a single centre experience. nameOfConference DOI: doi QMRO: qmroHref Davenport R, Coates A, Allard S et al. (2009). TRAUMA HAEMORRHAGE: EVOLVING ROLE OF ROTEM FOR PREDICTING TRANSFUSION REQUIREMENTS. nameOfConference DOI: doi QMRO: qmroHref Poller L, Keown M, Ibrahim S et al. (2008). An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. nameOfConference DOI: 10.1111/j.1538-7836.2008.02959.x QMRO: qmroHref Madhani M, Pasi KJ, Gutteridge CN et al. (2008). Preventing venous thromboembolism (VTE) in hospitalised patients: putting guidance into practice. nameOfConference DOI: doi QMRO: qmroHref MacCallum P, Madhani M, Mt-Isa S et al. (2007). Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.. nameOfConference DOI: 10.1002/pds.1347 QMRO: qmroHref Slater SE, Maccallum PK, Birjandi F et al. (1992). Acute myelogenous leukemia (AML) and diabetes insipidus (DI): Further association with monosomy 7. nameOfConference DOI: 10.1002/hon.2900100313 QMRO: qmroHref Whelan JS, Davis CL, Rohatiner AZS et al. (1992). Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy. nameOfConference DOI: 10.1002/hon.2900100204 QMRO: qmroHref Banerjee P, Maccallum PK, Walker RWH et al. (1995). Polyradiculopathy complicating acute lymphoblastic leukemia. nameOfConference DOI: 10.1002/hon.2900130106 QMRO: qmroHref Coats TJ, Brazil E, Heron M et al. (2006). Impairment of coagulation by commonly used resuscitation fluids in human volunteers. nameOfConference DOI: 10.1136/emj.2006.036574 QMRO: qmroHref Akinwunmi F, Engova D, Duggan C et al. (2006). Patient satisfaction as an anticoagulation service development tool. nameOfConference DOI: doi QMRO: qmroHref MacCallum PK, Hennessey EM, Beski S (2006). Incidence of pregnancy-associated venous thromboembolism.. nameOfConference DOI: 10.7326/0003-4819-144-6-200603210-00017 QMRO: qmroHref Donaldson GC, Seemungal TA, Patel IS et al. (2006). Airway and systemic inflammation and decline in lung function in patients with COPD Chest 2005;128:1995–2004. nameOfConference DOI: 10.1016/j.rmedu.2006.01.014 QMRO: qmroHref Gauthaman N, Holden E, Mandana R et al. (2006). Clinical outcome of high risk patients on enoxaparin during the antenatal period - a prospective study.. nameOfConference DOI: doi QMRO: qmroHref MACCALLUM PK, Madhani M (2006). Managing VTE. nameOfConference DOI: doi QMRO: qmroHref Donaldson GC, Seemungal TAR, Patel IS et al. (2005). Airway and systemic inflammation and decline in lung function in patients with COPD.. nameOfConference DOI: 10.1378/chest.128.4.1995 QMRO: qmroHref MacCallum PK (2005). Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers.. nameOfConference DOI: 10.1513/pats.200406-036MS QMRO: qmroHref MacCallum PK, Rudnicka AR, Rumley A et al. (2004). Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction. nameOfConference DOI: 10.1111/j.1365-2141.2004.05222.x QMRO: qmroHref Engova D, Duggan C, MacCallum P (2004). The role of medication adherence in warfarin anticoagulation control and its cognitive determinants. nameOfConference DOI: doi QMRO: qmroHref MacCallum PK, Cooper JA, Rumley A et al. (2004). Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease.. nameOfConference DOI: 10.1111/j.1538-7933.2004.0584l.x QMRO: qmroHref Hill AS, MacCallum PK, Young BD et al. (2003). Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy.. nameOfConference DOI: 10.1002/gcc.10277 QMRO: qmroHref Bowles LK, Cooper JA, Howarth DJ et al. (2003). Associations of haemostatic variables with body mass index: a community-based study.. nameOfConference DOI: 10.1097/00001721-200309000-00009 QMRO: qmroHref MacCallum PK, Rudnicka AR, Rumley A et al. (2003). Low-intensity warfarin reduces thrombin generation and fibrin turnover without affecting inflammation. nameOfConference DOI: doi QMRO: qmroHref Kennon S, Price CP, Mills PG et al. (2003). Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.. nameOfConference DOI: 10.1136/heart.89.1.36 QMRO: qmroHref MACCALLUM PK, Miller GJ, Meade TW (2003). The haemostatic system in arterial disease.. nameOfConference DOI: doi QMRO: qmroHref Seemungal TAR, Wedzicha JA, MacCallum PK et al. (2002). Chlamydia pneumoniae and COPD exacerbation.. nameOfConference DOI: 10.1136/thorax.57.12.1087-a QMRO: qmroHref Engova D, Duggan C, Shearer M et al. (2002). Effects of age and cytochrome P450 polymorphism on the maintenance dose of warfarin.. nameOfConference DOI: doi QMRO: qmroHref Jamshidi Y, Flavell DM, Hawe E et al. (2002). Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.. nameOfConference DOI: 10.1016/s0021-9150(02)00002-3 QMRO: qmroHref Gale CR, Ashurst HE, Hall NF et al. (2002). Size at birth and carotid atherosclerosis in later life. nameOfConference DOI: 10.1016/s0021-9150(01)00760-2 QMRO: qmroHref MACCALLUM PK (2002). Anticoagulant therapy following oral anticoagulant treatment for VTE.. nameOfConference DOI: doi QMRO: qmroHref Maccallum, Cooper, Martin et al. (1998). Associations of protein C and protein S with serum lipid concentrations. nameOfConference DOI: 10.1046/j.1365-2141.1998.00800.x QMRO: qmroHref Seemungal T, Harper-Owen R, Bhowmik A et al. (2001). Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.. nameOfConference DOI: 10.1164/ajrccm.164.9.2105011 QMRO: qmroHref MacCallum PK, Brennan PJ, Meade TW (2001). Minimum intensity anticoagulation therapy as primary prevention strategy - In reply. nameOfConference DOI: 10.1001/archinte.161.7.1015 QMRO: qmroHref Rohatiner AZS, LISTER TA, Dalley CD et al. (2001). Acute myelogenous leukaemia in patients 60 years and older, a retrospective analysis from St. Bartholomew's Hospital 1969-1999.. nameOfConference DOI: 10.1080/10245332.2001.11746568 QMRO: qmroHref MACCALLUM PK, Cavenagh J, Thomas JM et al. (2001). Optimising testing for phospholipid antibodies.. nameOfConference DOI: 10.1136/jcp.54.9.693 QMRO: qmroHref MACCALLUM PK, Barlow C, Edwards MJ et al. (2001). Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma.. nameOfConference DOI: 10.1023/a:1012248800195 QMRO: qmroHref MacCallum PK, Brennan PJ, Meade TW (2000). Minimum Effective Intensity of Oral Anticoagulant Therapy in Primary Prevention of Coronary Heart Disease. nameOfConference DOI: 10.1001/archinte.160.16.2462 QMRO: qmroHref Kennon S, Barakat K, Suliman A et al. (2000). Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction. nameOfConference DOI: 10.1136/heart.84.1.41 QMRO: qmroHref Roland MA, Seemungal TAR, Bhowmik A et al. (1999). P17 Effect of exacerbation on plasma levels of tissue factor in patients with COPD. nameOfConference DOI: 10.1097/00001721-199912000-00044 QMRO: qmroHref MacCallum PK, Meade TW (1999). Haemostatic function, arterial disease and the prevention of arterial thrombosis. nameOfConference DOI: 10.1053/beha.1999.0041 QMRO: qmroHref (1999). Preface. nameOfConference DOI: 10.1053/beha.1999.0027 QMRO: qmroHref Kennon S, Suliman A, MacCallum PK et al. (1998). Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. nameOfConference DOI: 10.1016/s0735-1097(98)00473-2 QMRO: qmroHref Seemungal T, MacCallum P, Wedzicha JA (1998). Plasma fibrinogen is a marker of COPD exacerbation. nameOfConference DOI: doi QMRO: qmroHref Poller L, Shiach C, MacCallum P et al. (1998). Multicentre randomised study of computerised anticoagulant dosage. nameOfConference DOI: 10.1016/s0140-6736(98)04147-6 QMRO: qmroHref MacCallum PK, Cooper JA, Meade TW et al. (1996). P26. Comparison of associations of prothrombin fragment F1.2 and D-dimer in a healthy population. nameOfConference DOI: 10.1097/00001721-199604000-00084 QMRO: qmroHref MacCallum PK, Cooper JA, Miller GJ et al. (1995). Determinants of the dilute clot lysis time (DCLT) in a healthy general practice-based population—the Harefield Study. nameOfConference DOI: 10.1097/00001721-199509000-00019 QMRO: qmroHref MacCallum PK, Rohatiner AZS, Davis CL et al. (1995). Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients. nameOfConference DOI: 10.1007/bf01696230 QMRO: qmroHref MacCallum PK, Meade TW, Cooper JA et al. (1995). Clotting factor VIII and risk of deep-vein thrombosis. nameOfConference DOI: 10.1016/s0140-6736(95)90689-4 QMRO: qmroHref Meade TW, Howarth DJ, Cooper J et al. (1994). Fibrinolytic activity and arterial disease. nameOfConference DOI: 10.1016/s0140-6736(94)92572-0 QMRO: qmroHref Rohatiner AZ, Johnson PW, Price CG et al. (1994). Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.. nameOfConference DOI: 10.1200/jco.1994.12.6.1177 QMRO: qmroHref MacCallum PK, Davis CL, Rohatiner AZ et al. (1993). Mitoxantrone and cytosine arabinoside as treatment for acute myelogenous leukemia (AML) at first recurrence.. nameOfConference DOI: doi QMRO: qmroHref Lillington DM, MacCallum PK, Lister TA et al. (1993). Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature.. nameOfConference DOI: doi QMRO: qmroHref Bassan R, Battista R, Rohatiner AZ et al. (1992). Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period.. nameOfConference DOI: doi QMRO: qmroHref Gibbons B, MacCallum P, Watts E et al. (1991). Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature.. nameOfConference DOI: doi QMRO: qmroHref Poller L, MacCallum PK, Thomson JM et al. (1990). Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.. nameOfConference DOI: 10.1136/hrt.63.4.231 QMRO: qmroHref MacCallum PK, Newbould MJ, Sambrook PS et al. (1988). Extramedullary haemopoietic tumours complicating polycythaemia vera.. nameOfConference DOI: 10.1136/jcp.41.6.609 QMRO: qmroHref MacCallum PK, Freemont AJ, Geary CG et al. (1988). A case of IgD myeloma presenting as diffuse osteosclerosis.. nameOfConference DOI: 10.1136/jcp.41.5.486 QMRO: qmroHref Smith SR, Auger MJ, Maccallum PK et al. (1987). HYPOTHYROIDISM AND VON WILLEBRAND'S DISEASE. nameOfConference DOI: 10.1016/s0140-6736(87)90565-4 QMRO: qmroHref Gozzard DI, MacCallum PK, Love EM (1986). Management of infection in the neutropenic patient. nameOfConference DOI: 10.1136/bmj.293.6547.627-b QMRO: qmroHref SupervisionMD(Res) Ruchika Kohli, British Society for Haematology Early Stage Grant, Evaluation of pharmacological thromboprophylaxis in renal transplantation: evidence, current practice, and haemostatic changes.